Ordered assembly of the amyloid-beta protein (A beta) into amyloid fib
rils is a critical step in Alzheimer's disease (AD). To release the am
yloidogenic peptide A beta from the Alzheimer amyloid precursor protei
n (APP), two secretases act sequentially: first, beta-secretase cleave
s close to the membrane within the ectodomain and then gamma-secretase
cuts within the transmembrane domain(1). The sites of gamma-secretase
cleavage are after residues 40 or 42 of A beta. Except in those rare
cases of AD caused by a mutation, levels of secreted A beta are not el
evated; thus, the secretory pathway may be unaffected, and factors oth
er than the extracellular concentration of A beta may contribute to th
e aggregation properties of the peptide. A beta is also present in int
racellular compartments(2-5). The two gamma-secretase cleavage product
s, A beta 42 and A beta 40, were found in different compartments: A be
ta 42 in the endoplasmic reticulum (ER)/intermediate compartment(3-5),
and A beta 40 in the trans-Golgi network(2,4) (TGN). The cellular com
partments that harbor A beta are target sites for therapeutic interven
tion. Here we report that in the brain, the principal compartment in w
hich A beta resides is a detergent-insoluble glycolipid-enriched membr
ane domain (DIG). Also present in the DIC fractions are the endoproteo
lytic fragments of presenilin-1 (PS1) and APP. The presence of these p
roteins, which all contribute to the generation of A beta, indicates t
hat the DIG fraction is probably where the intramembranous cleavage of
APP occurs.